Alimera Sciences reported $-3411000 in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Alimera Sciences ALIM:US USD -3411000 1.44M
Bayer BAYN:GR EUR 3.94B 2.59B
Insmed INSM:US USD -153275000 30.82M
Novartis NOVN:VX USD 3.1B 228M
Regeneron Pharmaceuticals REGN:US USD 1.18B 46.9M
Roche Holding ROG:VX 8.49B 3.05B